Neurocrine Biosciences Ownership | Who Owns Neurocrine Biosciences?

Overview Forecast RevenueFinancials Chart Transcripts

Neurocrine Biosciences Ownership Summary

Neurocrine Biosciences is owned by 98.92% institutional investors, 1.09% insiders. Blackrock is the largest institutional shareholder, holding 14.22% of NBIX shares. Dodge & Cox Stock I is the top mutual fund, with 3.94% of its assets in Neurocrine Biosciences shares.

NBIX Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Neurocrine Biosciences	98.92%	1.09%	-0.01%
Sector	Healthcare Stocks	35.49%	11.78%	52.72%
Industry	Biotech Stocks	34.84%	11.71%	53.45%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Blackrock	14.19M	14.22%	$1.95B
Blackrock funding, inc. /de	13.39M	13.45%	$1.76B
Vanguard group	9.70M	9.76%	$1.38B
Dodge & cox	5.46M	5.49%	$719.44M
Jpmorgan chase	5.44M	5.47%	$700.50M
Aqr capital management	4.94M	4.96%	$650.66M
State street	4.35M	4.38%	$573.67M
Two sigma investments, lp	3.06M	3.08%	$403.20M
Renaissance	2.42M	2.43%	$318.67M
Geode capital management	2.14M	2.15%	$280.80M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Sarissa capital management lp	116.53K	9.74%	$15.35M
Vestal point capital, lp	1.25M	4.60%	$164.68M
Avidity partners management lp	220.40K	2.95%	$30.08M
Braidwell lp	652.12K	2.87%	$85.91M
Iron triangle partners lp	131.39K	2.62%	$18.44M
Pfm health sciences, lp	215.68K	2.59%	$28.41M
Healthinvest partners ab	89.69K	2.54%	$7.85M
Arrowpoint investment partners (singapore) pte.	21.56K	2.52%	$2.84M
Dafna capital management	70.61K	2.12%	$9.30M
Birchview capital, lp	27.19K	2.04%	$3.58M

Top Buyers

Holder	Shares	% Assets	Change
Two sigma investments, lp	3.06M	0.33%	2.08M
Aqr capital management	4.94M	0.30%	1.67M
Vestal point capital, lp	1.25M	4.60%	1.25M
Norges bank	1.15M	0.02%	1.15M
Millennium management	1.25M	0.07%	804.58K

Top Sellers

Holder	Shares	% Assets	Change
Price t rowe associates inc /md/	151.26K	0.00%	-1.72M
Bellevue group	4.65K	0.01%	-1.70M
Los angeles capital management	149.11K	0.08%	-1.14M
Dsm capital partners	-	-	-932.60K
Point72 asset management	-	-	-837.43K

New Positions

Holder	Shares	% Assets	Change	Value
Vestal point capital, lp	1.25M	4.60%	1.25M	$164.68M
Norges bank	1.15M	0.02%	1.15M	$162.66M
Vanguard fiduciary trust	634.34K	0.02%	634.34K	$83.57M
Axa investment managers	323.90K	0.12%	323.90K	$45.47M
Aware super pty ltd as trustee of aware super	136.79K	0.27%	136.79K	$18.02M

Sold Out

Holder	Change
Wealthtrak capital management	-1.00
New millennium group	-1.00
American capital advisory	-1.00
Nemes rush group	-1.00
Wealth watch advisors	-1.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Mar 31, 2026	694	-6.72%	98,421,444	-0.74%	98	0.99%	373	-9.69%	211	-3.65%
Dec 31, 2025	286	-56.60%	23,096,413	-76.21%	23	0.24%	161	-53.47%	78	-63.72%
Sep 30, 2025	313	-46.40%	27,003,435	-70.64%	27	0.32%	165	-45.54%	95	-55.40%
Jun 30, 2025	588	0.17%	97,956,548	4.05%	98	1.11%	302	20.32%	215	-15.02%
Mar 31, 2025	585	-3.94%	94,105,380	-0.29%	94	1.07%	246	-24.31%	257	22.38%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Dodge & Cox Stock I	3.96M	3.94%	-
iShares Core S&P Mid-Cap ETF	3.39M	3.37%	-1.71K
Vanguard US Total Market Shares ETF	3.20M	3.21%	2.53K
Vanguard Total Stock Mkt Idx Inv	3.20M	3.18%	50.24K
Vanguard Small Cap Index	2.32M	2.30%	52.43K
BB Biotech AG Ord	1.76M	1.75%	-60.00K
JPMorgan Growth Advantage A	1.32M	1.32%	150.12K
Vanguard Small Cap Growth Index Inv	1.30M	1.29%	40.20K
JPMorgan Mid Cap Growth I	1.21M	1.20%	136.09K
JPM US Mid Cap Growth-Composite	1.21M	1.20%	132.21K

Recent Insider Transactions

Date	Name	Role	Activity	Value
May 15, 2026	POPS RICHARD F	-	Sell	$2.36M
May 12, 2026	Norwalk Leslie V	-	Sell	$590.60K
Jan 16, 2026	Gano Kyle	Chief Executive Officer	Sell	$240.48K
Jan 16, 2026	Gano Kyle	Chief Executive Officer	Sell	$4.59M
Dec 16, 2025	Norwalk Leslie V	-	Sell	$184.56K

Insider Transactions Trends

Date	Buy	Sell
2026 Q2	-	1
2026 Q1	-	2
2025 Q4	-	8
2025 Q3	-	4
2025 Q2	-	2

NBIX Ownership FAQ

Who Owns Neurocrine Biosciences?

Neurocrine Biosciences shareholders are primarily institutional investors at 98.92%, followed by 1.09% insiders and -0.01% retail investors. The average institutional ownership in Neurocrine Biosciences's industry, Biotech Stocks , is 34.84%, which Neurocrine Biosciences exceeds.

Who owns the most shares of Neurocrine Biosciences?

Neurocrine Biosciences’s largest shareholders are Blackrock (14.19M shares, 14.22%), Blackrock funding, inc. /de (13.39M shares, 13.45%), and Vanguard group (9.7M shares, 9.76%). Together, they hold 37.43% of Neurocrine Biosciences’s total shares outstanding.

Does Blackrock own Neurocrine Biosciences?

Yes, BlackRock owns 14.22% of Neurocrine Biosciences, totaling 14.19M shares as of Jun 2024. This represents 0.04% of BlackRock's total assets, with a market value of 1.95B$. In the last quarter, BlackRock increased its holdings by 429.74K shares, a 3.12% change.

Who is Neurocrine Biosciences’s biggest shareholder by percentage of total assets invested?

Sarissa capital management lp is Neurocrine Biosciences’s biggest shareholder by percentage of total assets invested, with 9.74% of its assets in 116.53K Neurocrine Biosciences shares, valued at 15.35M$.

Who is the top mutual fund holder of Neurocrine Biosciences shares?

Dodge & Cox Stock I is the top mutual fund holder of Neurocrine Biosciences shares, with 3.94% of its total shares outstanding invested in 3.96M Neurocrine Biosciences shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools